Federal health agencies call to pause Johnson & Johnson vaccine after clotting cases

Federal health agencies requested an abrupt pause in the use of Johnson & Johnson’s single-dose coronavirus vaccine after six U.S. recipients developed a rare disorder involving blood clots within nearly two weeks of vaccination, officials said on Tuesday.

The Food and Drug Administration, along with the Centers for Disease Control and Prevention, announced the news on Twitter and will reportedly stop distributing the vaccine at federal sites and encourage states to do so while an investigation is underway for safety issues.

“Today FDA and @CDCgov issued a statement regarding the...